Skip to main content
Top
Published in: Child's Nervous System 10/2007

01-10-2007 | Commentary

Proteus syndrome with syringohydromyelia and arachnoid cyst

Author: Fernando Rueda-Franco

Published in: Child's Nervous System | Issue 10/2007

Login to get access

Excerpt

The authors make a good review of the main clinical and genetic aspects of Proteus syndrome. They also describe new neuroimaging findings with clinical significance that must be added to the variety of abnormalities in these rare multi-organic neurocutaneous syndrome. With regard to molecular genetics, Zhou et al. [3] reported a boy with congenital hemihypertrophy, epidermoid nevi, macrocephaly, lipomas, arteriovenous malformations, and normal intellect. The patient had the clinical diagnosis of Proteus-like syndrome. Sequence analysis of DNA from peripheral blood revealed heterozygosity for a single base transversion resulting in an Arg 335 to Ter substitution of the phosphatase and tensin homolog (PTEN) gene product, whereas analysis of the DNA from nevus, lipoma, and arteriovenous mass also revealed heterozygosity for Arg 130 to Ter. The former mutation had been reported in patients with Cowden syndrome, whereas the latter mutation had been reported in individuals with Bannayan–Zonana syndrome. The authors postulated that the second hit, Arg 130 to Ter, occurred early in embryonic development and may even represent germline mosaicism. Thus, PTEN may be involved in Proteus-like syndrome with its implications for cancer development in the future. Five unrelated patients with Proteus syndrome had no demonstrable mutations in PTEN. …
Literature
1.
go back to reference Thiffault L, Schwartz CE, Der Kaloustian V, Foulkes WD (2004) Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am J Med Genet 130A:123–127CrossRef Thiffault L, Schwartz CE, Der Kaloustian V, Foulkes WD (2004) Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am J Med Genet 130A:123–127CrossRef
2.
go back to reference Smith JM, Kirk EPE, Theodosopoulos G, Marshall GM, Walker J, Rogers M, Field M, Brereton JJ, Marsh DJ (2002) Germline mutation of the tumour suppressor PTEN in Proteus syndrome. (Letter) J Med Genet 39:937–940PubMedCrossRef Smith JM, Kirk EPE, Theodosopoulos G, Marshall GM, Walker J, Rogers M, Field M, Brereton JJ, Marsh DJ (2002) Germline mutation of the tumour suppressor PTEN in Proteus syndrome. (Letter) J Med Genet 39:937–940PubMedCrossRef
3.
go back to reference Zhou X-P, Marsh DJ, Hampel H, Mulliken JB, Gimm O, Eng C (2000) Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Molec Genet 9:765–768CrossRef Zhou X-P, Marsh DJ, Hampel H, Mulliken JB, Gimm O, Eng C (2000) Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Molec Genet 9:765–768CrossRef
Metadata
Title
Proteus syndrome with syringohydromyelia and arachnoid cyst
Author
Fernando Rueda-Franco
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 10/2007
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-007-0367-9

Other articles of this Issue 10/2007

Child's Nervous System 10/2007 Go to the issue